Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Cash Flow-to-Debt Ratio
Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥234.19 Million could theoretically repay 0% of its total liabilities (CN¥1.62 Billion) in one year. Check Guizhou Xinbang Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guizhou Xinbang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Guizhou Xinbang Pharmaceutical Co Ltd across 19 annual periods. Check 002390 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Guizhou Xinbang Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Guizhou Xinbang Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥634.97 Million | CN¥2.01 Billion | ▼ -15.9% |
| 2023 | 0.38x | CN¥790.62 Million | CN¥2.10 Billion | ▲ +73.6% |
| 2022 | 0.22x | CN¥590.80 Million | CN¥2.73 Billion | ▲ +32.4% |
| 2021 | 0.16x | CN¥457.97 Million | CN¥2.80 Billion | ▼ -1.0% |
| 2020 | 0.17x | CN¥742.11 Million | CN¥4.49 Billion | ▲ +0.1% |
| 2019 | 0.17x | CN¥886.33 Million | CN¥5.37 Billion | ▲ +529.3% |
| 2018 | -0.04x | CN¥-218.56 Million | CN¥5.69 Billion | ▼ -199.0% |
| 2017 | 0.04x | CN¥201.74 Million | CN¥5.20 Billion | ▲ +184.3% |
| 2016 | -0.05x | CN¥-198.59 Million | CN¥4.31 Billion | ▼ -181.3% |
| 2015 | 0.06x | CN¥217.40 Million | CN¥3.84 Billion | ▲ +178.9% |
| 2014 | -0.07x | CN¥-198.60 Million | CN¥2.77 Billion | ▼ -51.7% |
| 2013 | -0.05x | CN¥-21.34 Million | CN¥450.69 Million | ▲ +59.5% |
| 2012 | -0.12x | CN¥-36.46 Million | CN¥311.99 Million | ▲ +22.6% |
| 2011 | -0.15x | CN¥-39.87 Million | CN¥264.02 Million | ▼ -1101.1% |
| 2010 | 0.02x | CN¥2.50 Million | CN¥165.81 Million | ▼ -92.1% |
| 2009 | 0.19x | CN¥41.75 Million | CN¥217.51 Million | ▲ +81.5% |
| 2008 | 0.11x | CN¥24.86 Million | CN¥235.04 Million | ▼ -29.3% |
| 2007 | 0.15x | CN¥32.49 Million | CN¥216.99 Million | ▲ +379.3% |
| 2006 | 0.03x | CN¥7.35 Million | CN¥235.18 Million | — |